Disorders of Excessive Somnolence: all 196 studies
Page 2 of 2. Open to participants first (34), then studies with results posted, then the rest; newest registration first within each.
- Whole Food Plant-based Diet Effect on Obstructive Sleep ApneaTerminatedNCT06395181Not applicable
- A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients with Obstructive Sleep Apnea (OSA)CompletedNCT06103825Phase 3
- Impact of Bright Light Therapy on Prader-Willi SyndromeActive, not recruitingNCT05939453Not applicable
- Disentangling the Role of Depression in HypersomniaCompletedNCT05850676
- Alternative Epworth Sleepiness Scale ESS-ALT in FrenchCompletedNCT05822128
- Multicenter Study on the Role of Neurodegeneration Biomarkers in Obstructive Sleep Apnea Syndrome With Residual Excessive Daytime Sleepiness.Status unknownNCT05795270
- Feasibility Study of At-Home EEG Monitoring for HypersomniaWithdrawnNCT05627388Not applicable
- Bright Light Therapy for Non-motor Symptoms in Parkinson's DiseaseCompletedNCT05524961Not applicable
- Integral Physiological Adaptations to Carbohydrate PeriodizationCompletedNCT05464342Not applicable
- A Multi-Signal Based Monitoring System for CNS HypersomniasStatus unknownNCT05443373
- Effects of Litebook EDGE™ Phototherapy on Academic Performance and Brain ActivityCompletedNCT05383690Not applicable
- Clinical and Neurophysiological Characteristics of NarcolepsyCompletedNCT05375890
- Sleep Disturbance in Chronic RhinitisCompletedNCT05312723
- Patient Outcomes in Unattended and In- Lab PolysomnographySuspendedNCT05230394Not applicable
- A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSACompletedNCT05223166Phase 3
- Analysis of New Salivary Biomarkers to Evaluate Excessive Diurnal Sleepiness in Children with HypersomniaCompletedNCT05183464
- OSA (oRisk of Obstructive Sleep Apnea and Traffic Accidents Among Bus Drivers in Ecuador: is There a Significant AssociationCompletedNCT05175287
- A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)CompletedNCT05113745Phase 3
- Lifestyle Medicine Strategies for Combating Sleepiness and Fatigue in Professional DriversWithdrawnNCT05096130Not applicable
- Sleep/Wake State Assessment with Non-invasive EarbudsCompletedNCT05066009Not applicable
- A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With NarcolepsyCompletedNCT05059223Phase 3
- Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease StudyWithdrawnNCT05056194Phase 2
- Delphi Consensus Excessive Daytime Sleepiness in OSACompletedNCT05055271
- Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral AdministrationCompletedNCT05008341Phase 1
- Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of NarcolepsyCompletedNCT04923594Phase 2
- The Effect of Acupressure on the Sleep Quality and Daytime SleepinessCompletedNCT04800939Not applicable
- Auditory Slow Wave Enhancement in Parkinson Disease and Mild Cognitive ImpairmentStatus unknownNCT04736017Not applicable
- Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human VolunteersTerminatedNCT04618263Phase 1
- Title: Effect of Therapeutic Touch on Daytime Sleepiness, Stress and FatigueCompletedNCT04515381Not applicable
- An Open Label Study of FT218 in Subjects With NarcolepsyCompletedNCT04451668Phase 3
- Daytime Sleepiness in Patients With the Assessment of a Sleep-related Respiratory DisorderStatus unknownNCT04448470
- 'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy'SuspendedNCT04419792
- Telemedicine and Humidification for Cpap IN Osas Key Treatment (THINK Study)Status unknownNCT04300166Not applicable
- Sleep in Psychiatric InpatientsStatus unknownNCT04201392
- Community-Level Daytime Sleepiness: Social-Environmental Determinants, Consequences, and Impact of Sleep ApneaCompletedNCT04176042Not applicable
- The Music, Sleep and Dementia StudyCompletedNCT04157244Not applicable
- Start Times and Restful SleepWithdrawnNCT04049682
- Psychosocial Adjunctive Treatment for Hypersomnia (PATH)CompletedNCT03904238Not applicable
- Validation of Non-invasive Miniature Optical Sensors for Scoring Sleep StagesCompletedNCT03823105Not applicable
- Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic HypersomniaWithdrawnNCT03626727Early Phase 1
- Importance of Sleep Deprivation in Differential Diagnosis of Primary Hypersomnia (Actisom dépistage)CompletedNCT03459300
- Validating the Use of a Subjectively Reported Sleep Vital SignCompletedNCT03018912Not applicable
- Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime SleepinessWithdrawnNCT02978651Phase 3
- Bright Light Therapy for Non-motor Symptoms in Parkinson's DiseaseActive, not recruitingNCT02909192Not applicable
- Improving the Assessment of HypersomnolenceCompletedNCT02884505
- The Effect of Caffeine on the Narcoleptic PatientsCompletedNCT02832336Phase 1/2
- Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSACompletedNCT02739568Phase 3
- Efficacy of Oral Appliance for Upper Airway Resistance SyndromeStatus unknownNCT02636621Not applicable
- Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's DiseaseTerminatedNCT02473562Phase 4
- CPAP to Reduce Arterial Stiffness in Non Sleepy, Moderate to Severe Obstructive Sleep Apnea (STIFFSLEEP)TerminatedNCT02273089
- A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and PharmacodynamicsCompletedNCT02215499Phase 1
- Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's DiseaseCompletedNCT02111122Phase 2
- Amylase and HypersomniaCompletedNCT01926405Not applicable
- Sleep Disorders and Their Cardiovascular Correlates in Atahualpa.CompletedNCT01877616Not applicable
- Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)CompletedNCT01800045Phase 3
- Palliative Morphine With or Without Concurrent ModafinilStatus unknownNCT01766323Phase 3
- Mindfulness Therapy on Disrupted Sleep in Bipolar DisorderCompletedNCT01764035Not applicable
- Circadian Rhythms and Sleep-Wake Cycles in Parkinson's DiseaseCompletedNCT01742182Not applicable
- Arousal Analysis by Pulse Wave Amplitude in Patients With Obstructive Sleep ApneaCompletedNCT01690429Not applicable
- Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.CompletedNCT01638403Phase 3
- Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)CompletedNCT01620554Phase 2
- Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's DiseaseTerminatedNCT01544465Not applicable
- Methylphenidate in Myotonic Dystrophy Type 1CompletedNCT01421992Phase 2/3
- Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)CompletedNCT01399606Phase 3
- Sleep Quality and Related Factors in Hemodialysis PatientsStatus unknownNCT01327560
- BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.CompletedNCT01072968Phase 3
- BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDSCompletedNCT01071876Phase 3
- Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With NarcolespyCompletedNCT01067235Phase 3
- Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in NarcolepsyCompletedNCT01067222Phase 3
- Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's DiseaseCompletedNCT01066442Phase 3
- Work Hour Reductions, Medical Errors, and Intern Well-Being at Providence St. Vincent Medical Center Intensive Care UnitCompletedNCT00996320Not applicable
- Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call ShiftsTerminatedNCT00983008Not applicable
- Method of Assessment of Driving Ability in Patients Suffering From Wakefulness PathologiesCompletedNCT00916253Not applicable
- Effects of Weight Reduction on Sleep and Alertness in Long-distance Truck and Bus DriversCompletedNCT00893646Not applicable
- Patient Preference, Sleep Quality, and Anxiety/Depression: A Randomized Comparison of Etravirine and EfavirenzCompletedNCT00792584Not applicable
- Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease PatientsCompletedNCT00642928Phase 2
- Cost/Effectiveness Analysis of the Respiratory Poligraphy at HomeCompletedNCT00614952Not applicable
- Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With SchizophreniaCompletedNCT00546403Not applicable
- A Combined Surgical and Medical Approach in Mild Sleep ApneaStatus unknownNCT00497120Not applicable
- Effect of Treating Sleep Apnea on Cognition in Patients With DementiaCompletedNCT00477828Not applicable
- Effects From a Mandibular Repositioning Appliance in Patients With Obstructive Sleep Apnea and SnoringCompletedNCT00477009Not applicable
- Effects of Hemodialysis on the Sleep/Wake CycleCompletedNCT00460863Phase 1
- Caffeine for Excessive Daytime Somnolence in Parkinson's DiseaseCompletedNCT00459420Phase 2/3
- Light Exposure to Treat Sleep Disruption in Older PeopleSuspendedNCT00427323Not applicable
- Down Syndrome and Continuous Positive Pressure TherapyCompletedNCT00394290Not applicable
- Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's DiseaseWithdrawnNCT00393562Not applicable
- Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive DisorderCompletedNCT00385437Phase 2
- Study to Determine the Effectiveness of Pillar Palatal Implants to Treat Obstructive Sleep ApneaCompletedNCT00307957Phase 4
- Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep ApneaCompletedNCT00307944Phase 4
- Restless Legs Syndrome Exercise InterventionStatus unknownNCT00258492Phase 1/2
- Provigil (Modafinil) Study by Taiwan Biotech Co.CompletedNCT00174174Not applicable
- Efficacy and Safety of DHEA for Myotonic DystrophyCompletedNCT00167609Phase 2/3
- Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea SyndromeCompletedNCT00107809Phase 3
- Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With NarcolepsyCompletedNCT00107796Phase 3
- Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic PatientsCompletedNCT00049803Phase 3
- Sleep Disorders of Patients With Diseases of the Nervous SystemCompletedNCT00001664